Gradalis
Gradalis is engaged in manufacturing drugs, vaccines, tools and diagnostics for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD239—359m (Dealroom.co estimates Apr 2018.)
Carrollton Texas (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $24.0m | Series B | |
| N/A | $43.9m | Late VC | |
* | $9.9m | Grant | |
| Total Funding | CAD106m | ||
Related Content
Recent News about Gradalis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.